Immix Biopharma Balance Sheet (2020-2026)

Reported Financials

Immix Biopharma Quarterly Balance Sheet

Periods 23 quarters

Latest Jun 2026

Immix Biopharma reported total assets of $0.24B and total liabilities of $0.01B for the quarter ended Jun 2026. This balance sheet covers 23 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.		17.64M	19.06M	18.40M	16.92M	13.44M	11.46M	12.65M	19.58M	17.51M	29.32M	23.98M	19.69M	17.68M	15.92M	11.64M	15.95M	93.93M	79.25M	225.49M
Short-term InvestmentsInvestments (Current)																		6.50M	11.33M	6.62M
Cash & Current Investments		17.64M	19.06M	18.40M	16.92M	13.44M	11.46M	12.65M	19.58M	17.51M	29.32M	23.98M	19.69M	17.68M	15.92M	11.64M	15.95M	100.40M	90.60M	232.10M
Receivables - OtherOther Receivables														1.90M	1.70M	1,700,000.00M	4.60M	2.80M	1.50M	2,000,000.00M
Current Deferred Tax AssetsCurrent Deferred Tax		-0.94M
Prepaid Assets		0.52M	0.89M	0.52M	0.29M	1.21M	1.25M	2.56M	2.10M	1.11M	1.57M	1.38M	1.09M	0.54M	0.86M	0.69M	0.64M	0.83M	1.70M	1.68M
Current Assets		18.19M	20.01M	19.08M	17.39M	14.90M	13.03M	15.51M	22.33M	19.79M	32.92M	27.33M	22.76M	20.20M	16.78M	12.33M	16.58M	101.24M	92.27M	233.79M
Non-Current Assets
Construction in Progress											0.31M			0.94M	1.18M
Property, Plant & Equipment (Net)PP&E (Net)		0.01M	0.01M	0.00M	0.00M	0.00M	0.05M	0.00M	0.04M	0.05M	0.36M	0.45M	1.36M	1.74M	2.12M	2.23M	2.36M	2.52M	2.43M	2.36M
Long-Term Investments																				2.10M
Long-Term Deferred Tax																		0.97M		0.89M
Other Non-Current Assets						0.01M	0.18M	0.06M	0.10M	0.09M	0.02M	0.02M	0.02M	0.02M	0.02M	0.13M	0.13M	0.11M	0.19M	0.02M
Non-Current Assets		0.01M	0.01M	0.00M	0.00M	0.01M	0.18M	0.06M	0.14M	0.14M	1.43M	1.51M	2.39M	2.75M	3.11M	3.31M	3.50M	3.60M	3.54M	5.32M
Assets		18.19M	20.02M	19.09M	17.40M	14.91M	13.21M	15.57M	22.47M	19.93M	34.35M	28.84M	25.14M	22.95M	19.89M	15.64M	20.08M	104.84M	95.82M	239.11M
Liabilities
Current Liabilities
Accounts Payables		0.14M	0.31M	0.98M	0.65M	1.27M	1.47M	2.40M	2.83M	3.72M	5.62M	3.85M	6.50M	8.62M	9.24M	9.94M	10.71M	9.97M	10.41M	9.19M
Notes Payables		0.05M	0.05M
Payables		0.19M	0.36M	0.98M	0.65M	1.27M	1.47M	2.40M	2.83M	3.72M	5.62M	3.85M	6.50M	8.62M	9.24M	9.94M	10.71M	9.97M	10.41M	9.19M
Accumulated Expenses		0.01M	0.01M						0.28M
Other Accumulated Expenses						0.44M			0.10M	0.10M	0.12M	0.07M	0.04M	0.13M	0.13M	0.05M	0.17M	0.33M	0.19M	0.05M
Short term Debt
Current Leases														0.07M				0.14M
Total Current Liabilities		0.20M	0.37M	0.98M	0.65M	1.27M	1.47M	2.40M	2.83M	3.72M	5.66M	3.90M	6.56M	8.69M	9.31M	10.01M	10.85M	10.11M	10.54M	9.30M
Non-Current Liabilities
Minority Interest							-0.03M	-0.06M	-0.12M	-0.20M	-0.28M
Operating Leases											1.06M	1.04M	1.03M	1.01M	0.99M	0.97M	0.97M	0.93M	0.91M	0.89M
Other Non-Current Liabilities		23.41M								0.32M
Total Non-Current Liabilities		-23.21M								3.40M
Total Liabilities		0.20M	0.37M	0.98M	0.65M	1.75M	1.47M	2.40M	2.83M	3.72M	6.72M	4.94M	7.59M	9.70M	10.30M	10.98M	11.82M	11.04M	11.45M	10.19M
Shareholder's Equity
Total Debt		0.05M	0.05M
Common Equity	-6.20M	17.99M	19.65M	18.11M	16.75M	13.16M	11.74M	13.17M	19.65M	16.20M	27.63M	23.89M	17.55M	13.25M	9.59M	4.65M	8.26M	93.80M	84.36M	228.92M
Liabilities and Shareholders Equity		18.19M	20.02M	19.09M	17.40M	14.91M	13.21M	15.57M	22.47M	19.93M	34.35M	28.84M	25.14M	22.95M	19.89M	15.64M	20.08M	104.84M	95.82M	239.11M
Treasury Stock				0.06M	0.06M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M	0.10M
Retained Earnings		-29.76M	-31.09M	-32.65M	-34.19M	-37.99M	-40.46M	-44.04M	-48.32M	-53.41M	-58.67M	-63.06M	-70.21M	-75.02M	-79.57M	-86.20M	-93.80M	-104.46M	-114.55M	-126.11M
Preferred Shares						0.00				0.00
Treasury Shares				0.04M	0.04M	0.07M	0.07M	0.07M	0.07M	0.07M	-0.07M	-0.07M	-0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M

Immix Biopharma Balance Sheet API

Pull Immix Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMMX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "IMMX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=IMMX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Immix Biopharma IMMX Balance Sheet (2020-2026)

Immix Biopharma Quarterly Balance Sheet

Immix Biopharma Balance Sheet API

Create an account

Sign In

Reset Password